Yahoo Finance screen flags NVIDIA alongside Neurocrine and Ball for improving earnings growth expectations

A market note published by Yahoo Finance on July 15 highlighted NVIDIA and two other publicly traded companies as potential candidates for earnings growth into the second half of 2026. The article frames its selection around a stock screen designed to surface companies where Wall Street expectations for profits are improving, rather than focusing on valuation alone.

According to the note’s premise, the screen looks for “earnings growth” characteristics and the direction of estimates. In practical terms, that typically means analysts’ forecast models are being revised upward over time, suggesting management teams are matching or exceeding expectations, or that demand and margins are trending in a favorable direction. The Yahoo Finance piece uses that framework to group three names: NVIDIA, Neurocrine Biosciences, and Ball Corporation.

NVIDIA (NASDAQ: NVDA) is the largest technology component of the list, reflecting the company’s outsized role in modern computing, including data center accelerators used for AI workloads. In a market narrative like this, NVIDIA’s inclusion indicates that the author(s) expect continued strength in profits or at least continued upward estimate revisions relative to peers, based on whatever data the screen pulled.

Neurocrine Biosciences is the second company named. Neurocrine is known as a specialty biopharmaceutical company, and when earnings-growth screens include biotech, it usually points to forecast momentum tied to pipeline progress, commercial execution, or updated guidance that changes expectations for future revenue and margins. The Yahoo Finance article presents Neurocrine as meeting the same broad earnings-growth and rising-estimate criteria as NVIDIA.

Ball Corporation is the third name. Ball is an industrial packaging and aerospace materials business, and its appearance in an earnings-growth screen generally implies expectations for improved profitability, often influenced by assumptions about pricing, volume, and cost trends across its major end markets.

While the Yahoo Finance note is clear about its selection logic, it does not, in the information available here, provide detailed line-item disclosures on what specific forecast metrics moved most for each company, or the size and timing of any estimate revisions. It also does not detail management-specific catalysts, such as contract wins, regulatory milestones, or product launches, within the summary description tied to the article.

In a broader context, earnings-growth screens tend to be closely watched by traders because upward estimate revisions can feed into near-term sentiment and, in some cases, price momentum. However, such screens can also be sensitive to analyst coverage changes, one-off forecast adjustments, and the inherent uncertainty of predicting margins and demand several quarters out. That uncertainty matters especially when the time horizon is “the second half of 2026,” which extends beyond the next typical quarterly reporting cycle.

For investors tracking this kind of setup, the key question is whether forecast momentum persists when companies report and when management comments either validate or contradict the assumptions embedded in analyst models. What to watch next for the three names is simple in principle: whether subsequent results and guidance keep the earnings trajectory aligned with the rising-expectation thesis that the Yahoo Finance screen aims to capture. A cautious reading would treat the list as a starting point for deeper diligence, not as a stand-alone thesis.